What Happened?
Boston, MA-based Akouos Resigned Alan Smith as Chief Technology Officer
About the Company
Akouos is a precision genetic medicine company dedicated to developing gene therapies that restore and preserve hearing. Leveraging its adeno-associated viral (AAV) vector-based gene therapy platform, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss. Headquartered in Boston, the Company was founded in 2016 by world leaders in the fields of neurotology, genetics, inner ear drug delivery, and AAV gene therapy. Akouos has strategic partnerships with Massachusetts Eye and Ear Infirmary and Lonza, Inc
About the Person
Alan Smith is Chief Technology Officer at Ambys. Previously, Alan held various senior IT leadership roles in the industry.
Info Source
News
Short Profile